- Medable Inc. is a leading technology platform for AI-powered clinical development, specializing in automating processes in clinical trials, particularly through its innovative Agentic AI solutions.
- In the past year, Medable launched several AI agents, including the Agentic AI for research sites and the TMF Agent, which streamline oversight and document management in clinical trials, significantly reducing manual effort.
- The company collaborates with various research sites and principal investigators, enhancing their operational efficiency and compliance in managing electronic clinical outcome assessments (eCOA) and trial master files (TMF).
- Medable's ideal buyers are clinical research organizations and pharmaceutical companies looking to reduce labor costs and improve efficiency in clinical trial management, making their recent AI advancements highly relevant for organizations facing operational bottlenecks.
Medable's workforce is organized into 13 departments, with Operations leading at 43 employees, followed closely by Information Technology with 39. Engineering and Sales departments contribute significantly with headcounts of 23 and 20, respectively. The distribution reflects a strong emphasis on operational and technical functions, which are critical for the company's software development focus. Additionally, a diverse range of other departments supports the overall functionality of the organization.
The geographic distribution of Medable's workforce spans 40 locations, with the largest concentration in Palo Alto, CA, housing 20 employees. Other notable locations include New York, NY, and San Jose, CA, each with 4 employees. The 'Other' category accounts for a substantial 145 employees, indicating a remote or distributed workforce model that enhances flexibility and access to talent. This distribution suggests a strategic approach to leveraging diverse geographic markets while maintaining a central operational hub.
